TVVFX
Price
$11.29
Change
-$0.09 (-0.79%)
Updated
Sep 6 closing price
VVIAX
Price
$65.30
Change
-$0.84 (-1.27%)
Updated
Sep 6 closing price
Ad is loading...

TVVFX vs VVIAX

Header iconTVVFX vs VVIAX Comparison
Open Charts TVVFX vs VVIAXBanner chart's image
Guggenheim RBP® Large-Cap Value P
Price$11.29
Change-$0.09 (-0.79%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$65.30
Change-$0.84 (-1.27%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TVVFX vs VVIAX Comparison Chart
Loading...
VS
TVVFX vs. VVIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TVVFX is a Buy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 183B vs. TVVFX (4.79M). VVIAX pays higher dividends than TVVFX: VVIAX (2.36) vs TVVFX (1.74). TVVFX was incepted earlier than VVIAX: TVVFX (13 years) vs VVIAX (24 years). TVVFX is a more actively managed with annual turnover of: 68.00 vs. VVIAX (10.00). TVVFX has a lower initial minimum investment than VVIAX: TVVFX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 19.30 vs. TVVFX (17.54). VVIAX return over 5 years is better than : 53.51 vs. TVVFX (22.18).
TVVFXVVIAXTVVFX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years24 years-
Gain YTD12.56213.50693%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.79M183B0%
Annual Yield % from dividends1.742.3674%
Returns for 1 year17.5419.3091%
Returns for 3 years-3.6519.68-19%
Returns for 5 years22.1853.5141%
Returns for 10 years9.16107.579%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDYN14.080.47
+3.45%
Grid Dynamics Holdings
USEG0.910.01
+1.00%
US Energy Corp
BCE35.950.07
+0.20%
BCE
LNKB6.15N/A
N/A
LINKBANCORP
CRNX50.98-1.82
-3.45%
Crinetics Pharmaceuticals